US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 0.895
  • -0.055-5.78%
Close Nov 15 16:00 ET
  • 0.881
  • -0.014-1.55%
Post 20:01 ET
48.94MMarket Cap-2486P/E (TTM)

About Cytosorbents Company

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Company Profile

SymbolCTSO
Company NameCytosorbents
Listing DateDec 23, 2014
Founded1997
CEODr. Phillip P. Chan, M.D.,PhD
MarketNASDAQ
Employees186
Fiscal Year Ends12-31
Address305 College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-732-329-8885
Websitehttp://cytosorbents.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Phillip P. Chan, M.D.,PhD
  • Chief Executive Officer and Director
  • 1.33M
  • Vincent J. Capponi, M.S.
  • President and Chief Operating Officer
  • 1.11M
  • Peter J. Mariani
  • Chief Financial Officer
  • --
  • Dr. Efthymios Nikolaos Deliargyris, M.D.
  • Chief Medical Officer
  • 1.06M
  • Michael G. Bator
  • Chairman of the Board
  • 161.70K
  • Jiny Kim, M.B.A.
  • Independent Director
  • 101.80K
  • Alan D. Sobel, C.P.A.
  • Independent Director
  • 118.47K
  • Dr. Edward R. Jones, M.B.A.,M.D.
  • Independent Director
  • 101.93K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data